Approved Clinical Trial Applications can be found in The European Union Clinical Trials Register
The IMA has approved the following clinical trials in Iceland
The IMA approved five clinical trials in the year 2019
On the 10th of October 2019 IMA approved a multinational phase III trial for oncology.
On the 26th of June 2019 IMA approved a multinational phase II trial for atopic dermatitis.
On the 6th of March 2019 IMA approved a clinical trial for a genetic disease. This is a phase IIa trial only performed in Iceland.
On the 4th of March 2019 IMA approved a multinational phase II trial for atopic dermatitis.
On the 4th of March 2019 IMA approved a multinational phase IIIb trial for atopic dermatitis.
The IMA approved three clinical trials in the year 2018
On 12 December 2018 IMA approved a multinational phase II trial in oncology.
On the 29th of November 2018 IMA approved a trial in oncology. This is a phase II trial only performed in Iceland.
On the 29th of May 2018 IMA approved a multinational phase II trial for atopic dermatitis.
The IMA approved five clinical trials in the year 2017
On the 22nd of September IMA approved a multinational phase II/III trial for dementia.
On the 11th of April 2017 IMA approved a trial in cardiology. This is a phase IV trial only performed in Iceland.
On the 11th of April 2017 IMA approved a multinational phase IIIb trial in rheumatology.
On the 27th of March 2017 IMA approved a multinational phase IIIb trial in cardiology.
On the 12th of January 2017 IMA approved a multinational phase III trial in dermatology.
The IMA approved nine clinical trials in the year 2016
On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 21 December 2016 IMA approved a multinational phase IIb/III trial in gastroenterology.
On 21 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 21 September 2016 IMA approved a multinational phase IIIb trial in dermatology.
On 8 June 2016 IMA approved a multinational phase IV trial in oncology.
On 4 May 2016 IMA approved a multinational phase III trial in dermatology.
On 28 April 2016 IMA approved a multinational phase II/III trial in gastroenterology.
On 7 April 2016 IMA approved a multinational phase II trial in gastroenterology.
The IMA approved seven clinical trials in the year 2015
On 29 December 2015 IMA approved a multinational phase III trial in respiratory disease.
On 30 November 2015 IMA approved a clinical trial in dermatology. This is a phase IV trial only performed in Iceland.
On 2 July 2015 IMA approved a multinational phase II trial in immunology.
On 29 June 2015 IMA approved a trial in gastroenterology. This is a phase IV trial only performed in Iceland.
On 17 March 2015 IMA approved a multinational phase III trial in cardiology.
On 10 February 2015 IMA approved multinational phase III trial in cardiology.
On 23 January 2015 IMA approved a multinaltional phase II trial in dermotology.